1-9 of 9
Sheh-Li Chen
Close
Sort by
Journal Articles

Real-World Experience of Ropeginterferon-Alfa Treatment of PV and ET - Two Centers Experience

Tsewang Tashi, Brandi N. Reeves, Soo Jin Kim, Hyewon Jeong, Sheh-Li Chen, Brynn Parsegov, Josef T. Prchal
Journal: Blood
Blood (2023) 142 (Supplement 1): 6397.
https://doi.org/10.1182/blood-2023-191268
Published: 2023
Journal Articles

Ropegiterferon Alfa-2b-Njft for Treatment Myeloproliferative Neoplasms: A Single Institution Experience

Callie Berkowitz, Sheh-Li Chen, Brandi Reeves
Journal: Blood
Blood (2022) 140 (Supplement 1): 12254–12255.
https://doi.org/10.1182/blood-2022-164733
Published: 2022
Journal Articles

Rituximab Monotherapy Is Effective for Inhibitor Eradication with Concomitant Porcine Factor VIII Followed By Emicizumab for Bleed Control in Acquired Hemophilia a

Patrick Ellsworth, Sheh-Li Chen, Christopher Wang, Nigel S Key, Alice Ma
Journal: Blood
Blood (2021) 138 (Supplement 1): 348.
https://doi.org/10.1182/blood-2021-154207
Published: 2021
Journal Articles

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Anqi Zhu, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 792.
https://doi.org/10.1182/blood-2019-121340
Published: 2019
Journal Articles

Incidence and Time Course of Neutropenia in Patients Treated with Rituximab-Based Therapy for Non-Malignant Immune-Mediated Hematologic Diseases

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Anqi Zhu, MS, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 390.
https://doi.org/10.1182/blood-2019-121343
Published: 2019
Journal Articles

Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Nigel S. Key, MBChB, FRCP, Raj S. Kasthuri, MD, Micah J. Mooberry, MD, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2474.
https://doi.org/10.1182/blood-2018-99-118839
Published: 2018
Journal Articles

Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Yasmina L. Abajas, MD, Stephan Moll, MD, Nigel S. Key, MBChB, FRCP, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1202.
https://doi.org/10.1182/blood-2018-99-119196
Published: 2018
Journal Articles

Importance of Pharmacokinetic Studies in the Management of Acquired Factor X Deficiency

Ming Yeong Lim, MBBChir, Timothy A. McCarthy, MD, Sheh-Li Chen, Pharm D, Alice D Ma, MD
Journal: Blood
Blood (2014) 124 (21): 5059.
https://doi.org/10.1182/blood.V124.21.5059.5059
Published: 2014
Journal Articles

Investigation Of a Cluster Of Inhibitors Among Previously Treated Hemophilia Patients (PTPs) At A Single Hospital In The United States

Nafisa Ghaji, MB BS MPH, Nigel S Key, MBChB, Connie H. Miller, PhD, Brenda Nielsen, MSN, RN, Tyler W. Buckner, MD, Sheh-Li Chen, Pharm D, W Craig Hooper, PhD, J. Michael Soucie, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1114.
https://doi.org/10.1182/blood.V122.21.1114.1114
Published: 2013